
EYE vs RXST
$EYE vs $RXST head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
EYE vs RXST: the quick read
- ·EYE is the larger company by market cap ($1.33B vs $216M).
- ·EYE has been more active on our scanner (94 vs 44 alerts in 30 days).
- ·RXST has the smaller float (37.4M vs 77.2M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (OPHTHALMIC GOODS vs Ophthalmic Goods), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 94 and 44 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·EYE is the one in play today, trading about 2.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing EYE and RXST on TheDesperateTrader.
- Is EYE or RXST the better stock?
- "Better" depends on your goal, and these two are not alike. EYE is the larger company by market cap ($1.33B vs $216M). EYE has been more active on our scanner (94 vs 44 alerts in 30 days). RXST has the smaller float (37.4M vs 77.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between EYE and RXST?
- The differences that matter: they are not in the same business - EYE is ophthalmic goods and RXST is ophthalmic goods; EYE is roughly 6x the size of the other by market cap ($1.33B vs $216M); they trade at very different share prices ($16.88 vs $5.17); EYE sits at 14% of its 52-week range against 8% for RXST; our scanner flagged EYE 94 times in the last 30 days against 44 for RXST. Everything above is measured from the latest completed session and SEC filings.
- Which of EYE and RXST is more active right now?
- Right now EYE is at about 2.2x its normal volume and RXST is at about 1.3x, so EYE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading EYE or RXST? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore EYE and RXST comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.